Europe Huntingtons Disease Treatment Market Size & Outlook

The huntingtons disease treatment market in Europe is expected to reach a projected revenue of US$ 515.7 million by 2030. A compound annual growth rate of 23.3% is expected of Europe huntingtons disease treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$141.6
Forecast, 2030 (US$M)
$515.7
CAGR, 2025 - 2030
23.3%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe huntingtons disease treatment market, 2018-2030 (US$M)

Europe huntingtons disease treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Europe huntingtons disease treatment market highlights

  • The Europe huntingtons disease treatment market generated a revenue of USD 141.6 million in 2024.
  • The market is expected to grow at a CAGR of 23.3% from 2025 to 2030.
  • In terms of segment, symptomatic treatment was the largest revenue generating treatment in 2024.
  • Symptomatic Treatment is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.

Europe data book summary

Market revenue in 2024USD 141.6 million
Market revenue in 2030USD 515.7 million
Growth rate23.3% (CAGR from 2025 to 2030)
Largest segmentSymptomatic treatment
Fastest growing segmentSymptomatic Treatment
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSymptomatic Treatment
Key market players worldwideH. Lundbeck AS Class A, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Hetero, Lupin, Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd ADR, Sun Pharmaceutical Industries

Other key industry trends

  • In terms of revenue, Europe region accounted for 28.3% of the global huntingtons disease treatment market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 525.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Huntingtons Disease Treatment Market Companies

Name Profile # Employees HQ Website

Europe huntingtons disease treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to huntingtons disease treatment market will help companies and investors design strategic landscapes.


Symptomatic treatment was the largest segment with a revenue share of 127.82% in 2024. Horizon Databook has segmented the Europe huntingtons disease treatment market based on symptomatic treatment covering the revenue growth of each sub-segment from 2018 to 2030.


The Huntington’s disease treatment market in Europe is expected to grow at a significant rate due to combined efforts of many governments & private institutes, such as European Huntington’s Disease Network (EHDN) and European Huntington Association, which plan to develop a unique program focusing on multiple approaches in drug development.

For instance, in March 2021, F. Hoffmann La Roche Ltd. halted dosing in phase 3 clinical trial of Tominersen in patients suffering from HD. Tominersen was designed to reduce synthesis of all versions of the Huntingtin Protein (HTT), including the mutant variant that causes HD.

Reasons to subscribe to Europe huntingtons disease treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe huntingtons disease treatment market databook

  • Our clientele includes a mix of huntingtons disease treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe huntingtons disease treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe huntingtons disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe huntingtons disease treatment market size, by country, 2018-2030 (US$M)

Europe Huntingtons Disease Treatment Market Outlook Share, 2024 & 2030 (US$M)

Europe huntingtons disease treatment market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online